Inflammatory Arthritis and Bone Metabolism Regulated by Type 2 Innate and Adaptive Immunity
Open Access
- 20 January 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (3) , 1104
Abstract
While type 2 immunity has traditionally been associated with the control of parasitic infections and allergic reactions, increasing evidence suggests that type 2 immunity exerts regulatory functions on inflammatory diseases such as arthritis, and also on bone homeostasis. This review summarizes the current evidence of the regulatory role of type 2 immunity in arthritis and bone. Key type 2 cytokines, like interleukin (IL)-4 and IL-13, but also others such as IL-5, IL-9, IL-25, and IL-33, exert regulatory properties on arthritis, dampening inflammation and inducing resolution of joint swelling. Furthermore, these cytokines share anti-osteoclastogenic properties and thereby reduce bone resorption and protect bone. Cellular effectors of this action are both T cells (i.e., Th2 and Th9 cells), but also non-T cells, like type 2 innate lymphoid cells (ILC2). Key regulatory actions mediated by type 2 cytokines and immune cells on both inflammation as well as bone homeostasis are discussed.Keywords
Funding Information
- Japan Society for the Promotion of Science (19H05654, 19KK0226)
This publication has 115 references indexed in Scilit:
- Systemically dispersed innate IL-13–expressing cells in type 2 immunityProceedings of the National Academy of Sciences, 2010
- IL25 elicits a multipotent progenitor cell population that promotes TH2 cytokine responsesNature, 2010
- Nuocytes represent a new innate effector leukocyte that mediates type-2 immunityNature, 2010
- The genetics and epigenetics of autoimmune diseasesJournal of Autoimmunity, 2009
- IL-4–producing CD4+ T cells in reactive lymph nodes during helminth infection are T follicular helper cellsJournal of Experimental Medicine, 2009
- IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3− effector T cellsNature Immunology, 2008
- IL-33 exacerbates antigen-induced arthritis by activating mast cellsProceedings of the National Academy of Sciences, 2008
- IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC–activated Th2 memory cellsJournal of Experimental Medicine, 2007
- Interleukin‐4 inhibition of osteoclast differentiation is stronger than that of interleukin‐13 and they are equivalent for induction of osteoprotegerin production from osteoblastsImmunology, 2007
- Effect of interleukin-4 on vascular endothelial growth factor production in rheumatoid synovial fibroblastsClinical and Experimental Immunology, 2006